ROCKWELL MEDICAL, INC.
ROCKWELL MEDICAL, INC. (RMTI): 14 pipeline candidates · ~320 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
319.9 months
D/E 0.60 · 0% dilution
N/A
14 candidates
N/A
0 buys · 2 sells (180d)
A transparent, data-derived signal for ROCKWELL MEDICAL, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$24.7M
Cash
$9.6M
Quarterly Burn
$167K
Runway
319.9 mo
Revenue
$17.3M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (14 candidates)
Showing 10 of 14 candidates. Sign up for full pipeline.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
40
Total value held
$4.2M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 2,364,722 | $2.1M |
| renaissance technologies llc | 639,120 | $571K |
| geode capital management, llc | 429,180 | $383K |
| blackrock, inc. | 236,671 | $211K |
| vanguard fiduciary trust co | 231,258 | $207K |
| northern trust corp | 104,523 | $93K |
| state street corp | 100,904 | $90K |
| jane street group, llc | 78,956 | $71K |
| perkins capital management inc | 70,371 | $63K |
| panagora asset management inc | 69,726 | $62K |
Showing top 10 of 40 institutional holders of ROCKWELL MEDICAL, INC.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in ROCKWELL MEDICAL, INC.'s pipeline?
ROCKWELL MEDICAL, INC. (RMTI) has 14 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is ROCKWELL MEDICAL, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, ROCKWELL MEDICAL, INC. has approximately 319.9 months of cash runway.
What is ROCKWELL MEDICAL, INC.'s market capitalization?
ROCKWELL MEDICAL, INC.'s market capitalization is approximately $24.7M.
Who is the CEO of ROCKWELL MEDICAL, INC.?
Dr. Mark Strobeck Ph.D. is the chief executive officer of ROCKWELL MEDICAL, INC. (RMTI).
Get the full picture on ROCKWELL MEDICAL, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.